Data Insights

BGBA-445 by BeiGene for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval

BGBA-445 is under clinical development by BeiGene and currently in Phase II for Squamous Non-Small Cell Lung Cancer. According to...

Likelihood of Approval and Phase Transition Success Rate Model - BGBA-445 in Squamous Non-Small Cell Lung Cancer

Data Insights

BGBA-445 by BeiGene for Nasopharyngeal Cancer: Likelihood of Approval

BGBA-445 is under clinical development by BeiGene and currently in Phase II for Nasopharyngeal Cancer. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - BGBA-445 in Nasopharyngeal Cancer

Data Insights

BGBA-445 by BeiGene for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval

BGBA-445 is under clinical development by BeiGene and currently in Phase II for Recurrent Head And Neck Squamous Cell Carcinoma....

Data Insights

BGBA-445 by BeiGene for Advanced Malignancy: Likelihood of Approval

BGBA-445 is under clinical development by BeiGene and currently in Phase III for Advanced Malignancy. According to GlobalData, Phase III...

Data Insights

BGBA-445 by BeiGene for Non-Small Cell Lung Cancer: Likelihood of Approval

BGBA-445 is under clinical development by BeiGene and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...

Data Insights

BGBA-445 by BeiGene for Solid Tumor: Likelihood of Approval

BGBA-445 is under clinical development by BeiGene and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...

Data Insights

BGBA-445 by BeiGene for Nasopharyngeal Cancer: Likelihood of Approval

BGBA-445 is under clinical development by BeiGene and currently in Phase II for Nasopharyngeal Cancer. According to GlobalData, Phase II...